Cargando…

Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers

BACKGROUND: A growing amount of scientific evidence suggests that microbes are involved in the aetiology of irritable bowel syndrome (IBS), and the gastrointestinal (GI) microbiota of individuals suffering from diarrhoea-predominant IBS (IBS-D) is distinguishable from other IBS-subtypes. In our stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krogius-Kurikka, Lotta, Lyra, Anna, Malinen, Erja, Aarnikunnas, Johannes, Tuimala, Jarno, Paulin, Lars, Mäkivuokko, Harri, Kajander, Kajsa, Palva, Airi
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807867/ https://www.ncbi.nlm.nih.gov/pubmed/20015409 http://dx.doi.org/10.1186/1471-230X-9-95

Ejemplares similares

Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes
por: Lyra, Anna, et al.
Publicado: (2010)

Sequence analysis of percent G+C fraction libraries of human faecal bacterial DNA reveals a high number of Actinobacteria
por: Krogius-Kurikka, Lotta, et al.
Publicado: (2009)

Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects
por: Rinttilä, Teemu, et al.
Publicado: (2011)

Faecal Microbiota Composition in Adults Is Associated with the FUT2 Gene Determining the Secretor Status
por: Wacklin, Pirjo, et al.
Publicado: (2014)

Acupuncture for Diarrhoea-Predominant Irritable Bowel Syndrome: A Network Meta-Analysis
por: Zhu, Lingping, et al.
Publicado: (2018)

Review article: an analysis of safety profiles of treatments for diarrhoea‐predominant irritable bowel syndrome
por: Lacy, Brian E.
Publicado: (2018)

Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?
por: Chakraborty, Dwaipayan Sarathi, et al.
Publicado: (2019)

Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity
por: Prospero, Laura, et al.
Publicado: (2021)

Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome
por: Yang, Jingze, et al.
Publicado: (2021)

Randomized Clinical Trial: The Clinical Effects of Herb-Partitioned Moxibustion in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome
por: Ma, Yu-xia, et al.
Publicado: (2013)

Randomised clinical trial: exploratory phase 2 study of ONO‐2952 in diarrhoea‐predominant irritable bowel syndrome
por: Whitehead, W. E., et al.
Publicado: (2016)

Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome
por: Fodor, Anthony A., et al.
Publicado: (2018)

Effects of herb-partitioned moxibustion for diarrhoea-predominant irritable bowel syndrome: A protocol for systematic review and meta-analysis
por: Wang, Fen, et al.
Publicado: (2020)

Phytoplankton Morpho-Functional Trait Variability along Coastal Environmental Gradients
por: Lehtinen, Sirpa, et al.
Publicado: (2021)

Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study
por: Linsalata, Michele, et al.
Publicado: (2018)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
por: Jabbar, Karolina S, et al.
Publicado: (2021)

Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial
por: Leighton, Matthew P, et al.
Publicado: (2013)

Antibiotic exposure among young infants suffering from diarrhoea in Bangladesh
por: Islam, Md Ridwan, et al.
Publicado: (2020)

Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways
por: Hou, Qiuke, et al.
Publicado: (2019)

Impact of symptom severity in patients with diarrhoea-predominant irritable bowel syndrome (IBS-D): results from two separate surveys of HCPs and patients with IBS-D
por: Emmanuel, Anton, et al.
Publicado: (2020)

High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria
por: Shiha, Mohamed G., et al.
Publicado: (2020)

Genome Sequences of Four Staphylococcus aureus Strains Isolated from Bovine Mastitis
por: Kant, Ravi, et al.
Publicado: (2015)

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
por: Garsed, Klara, et al.
Publicado: (2014)

Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations
por: Pardo-Camacho, Cristina, et al.
Publicado: (2022)

Constipation-Predominant Irritable Bowel Syndrome Associated to Hyperprolactinemia
por: Seretis, C., et al.
Publicado: (2011)

Targeted therapies for diarrhea-predominant irritable bowel syndrome
por: Olden, Kevin W
Publicado: (2012)

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
por: Lacy, Brian E
Publicado: (2016)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Özdener, Ayşe Elif, et al.
Publicado: (2017)

Comparative genome analysis of Lactobacillus casei strains isolated from Actimel and Yakult products reveals marked similarities and points to a common origin
por: Douillard, François P, et al.
Publicado: (2013)

Genetic characterization of a new astrovirus detected in dogs suffering from diarrhoea
por: Toffan, Anna, et al.
Publicado: (2009)

Diarrhoea as the presenting sign in an adolescent suffering from severe acute respiratory syndrome
por: Kwan, Yat Wah, et al.
Publicado: (2005)

Comparison of Quality of Life and Psychiatric Symptoms Between Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Those With Constipation-Predominant Irritable Bowel Syndrome
por: BOUSABA, J., et al.
Publicado: (2023)

Long-term safety and efficacy study of a medical device containing xyloglucan, pea protein reticulated with tannins and xylo-oligosaccharides, in patients with diarrhoea-predominant irritable bowel syndrome
por: de los Rios, Constanza Ciriza, et al.
Publicado: (2021)

A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites
por: Chojnacki, Cezary, et al.
Publicado: (2022)

Comparative genome analysis of 24 bovine-associated Staphylococcus isolates with special focus on the putative virulence genes
por: Åvall-Jääskeläinen, Silja, et al.
Publicado: (2018)

Characterization of the bacterial gut microbiota of piglets suffering from new neonatal porcine diarrhoea
por: Hermann-Bank, Marie Louise, et al.
Publicado: (2015)

Lactobacillus surface layer proteins: structure, function and applications
por: Hynönen, Ulla, et al.
Publicado: (2013)

Diarrhea-Predominant Irritable Bowel Syndrome: Medical Management Update
por: Andrews, Christopher N, et al.
Publicado: (2019)

Efficacy and Safety of Acupoint Catgut Embedding for Diarrhea-Predominant Irritable Bowel Syndrome and Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
por: Wu, Jing, et al.
Publicado: (2020)

Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0o1tpvh83i11c5e9cm1pc9ig1e